Quick Answer: Evernorth reports its XRP at historical cost less accumulated impairment under the accounting policy described in its September 2026 Form 10-Q. The filing lists $846.6 million of original additions and a $341.9 million carrying value at 30 September 2026. The difference is about 59.6% of original cost, but it spans impairments recorded in 2025 and 2026. The balance fell 44.2% from its $612.9 million carrying value at 31 December 2025. Neither percentage, by itself, means Evernorth sold that proportion of its XRP or that its holdings were worth $341.9 million at the market close.
Which numbers does the filing report?
The starting point is Evernorth Holdings Inc.'s Form 10-Q, not a headline about a single quarter. Note 4 provides a roll-forward of the digital-asset carrying amount. The filing says the digital assets consist solely of XRP. Its columns cover different periods: inception to December 2025, the three months ended September 2026, and the nine months ended September 2026.
| Filing period and measure | USD | What it means |
|---|---|---|
| Additions from inception through 2025 | 846,575,043 | Original recorded cost of contributed XRP |
| Impairment through 31 December 2025 | (233,650,642) | Prior-period reductions |
| Carrying value, 31 December 2025 | 612,924,401 | Starting balance for 2026 |
| Impairment, first nine months of 2026 | (271,037,170) | Additional reductions during 2026 |
| Carrying value, 30 September 2026 | 341,887,231 | Balance after accumulated impairment |
| Impairment, third quarter 2026 only | (6,891,073) | A subset of the nine-month amount |
Source: Evernorth Form 10-Q, Note 4. Values are reported dollars, not live XRP prices.
The arithmetic is direct. Original additions of $846,575,043 less the 2025 impairment of $233,650,642 equal $612,924,401. Subtract the 2026 nine-month impairment of $271,037,170 and the balance becomes $341,887,231. The third-quarter charge of $6,891,073 is included in the nine-month figure; adding both would double-count it. That is an easy error when a filing presents quarter and year-to-date tables side by side.
Where does the “60%” headline come from?
It compares the September 2026 carrying value with the original $846.6 million addition. The cumulative reduction is $504.7 million, or approximately 59.6% of that original amount. Rounding produces “60%.” It does not describe an impairment charge booked entirely in the September quarter.
A different question uses a different denominator. Compared with the $612.9 million balance on 31 December 2025, the $271.0 million decline in the first nine months of 2026 is approximately 44.2%. The third quarter alone reduced the 1 July 2026 balance of $348.8 million by $6.9 million, or about 2.0%. Each calculation is valid for its stated period; none should be substituted for another.
These comparisons concern a book balance. To assess whether the company sold XRP, one would review the holdings, disposition disclosures, and cash-flow statements. An impairment entry reduces the asset's carrying amount and records a charge in the statement of operations; it does not, by itself, transfer tokens to a buyer or create cash proceeds. The filing's Note 4 roll-forward shows no additions in the third quarter. Do not infer a complete transaction history from one balance-sheet line.
Why is the accounting value different from a quoted XRP price?
The filing states that Evernorth accounts for its XRP as an indefinite-lived intangible asset under ASC 350, initially at cost and thereafter at cost less accumulated impairment. Management says it considers the lowest observable intraday price on its principal market since acquisition of the particular XRP lot. If that low falls below the lot's carrying amount, it records a loss and reduces the basis. The lower amount is not subsequently written up merely because the quoted price recovers. A gain can be recognized on a later disposition, under the company's stated policy.
This makes the carrying amount path-dependent. Two companies can hold the same number of XRP on the same reporting date yet report different carrying amounts if they acquired different lots at different prices or applied different accounting policies. The reported number is a result of the applicable recognition and measurement rules, not a universal XRP price multiplied by tokens held.
Evernorth says its holdings do not meet the scoping criteria of ASU 2023-08's crypto-asset fair-value model and that it will continue to use cost less impairment. The filing describes its reasoning and its selected principal market, Coinbase, for impairment purposes. Readers should not generalize this treatment to every corporate XRP holder. Accounting depends on the specific asset, holder, relationship, reporting framework and effective rules. The company's own note is the source for its conclusion; an article should not silently replace it with a generic “crypto is marked to market” claim.
The filing also refers to a September 30 Coinbase closing quote of $1.49 in the measurement of a separate refundable-investor-advance liability. That quote is a point-in-time market input for a stated purpose. It should not be confused with the asset's cost-less-impairment carrying amount, and the liability's valuation model should not be presented as the value of the XRP asset line.
Does the write-down mean Evernorth lost cash or sold XRP?
The impairment is a noncash accounting charge when recognized. It reports a reduction in the asset's carrying amount and affects reported earnings or loss. It does not require the company to sell tokens, pay a creditor or withdraw cash on that date. Economic exposure remains: a holder can still gain or lose from later XRP price changes, and its ability to monetize holdings depends on restrictions, market depth and transaction terms.
The filing says certain contributed XRP was held in a custodial wallet under contractual restrictions before completion of a business combination. Those restrictions matter to liquidity and transaction planning. They also show why “what the balance sheet says” and “what the company can sell immediately” are separate questions. The article cannot conclude from the carrying value alone how much unrestricted XRP Evernorth could have disposed of on 30 September.
Nor does a noncash charge mean the underlying price move was irrelevant. A lower quoted price can trigger the accounting reduction. It is a mistake in the other direction to say the loss is “only paper” and dismiss the market exposure. The accounting entry and the market risk are different measurements of a related asset. If prices later recover, the company can have more market value than book value while its reported asset remains at its impaired basis until the rules permit recognition through another event.
How should a reader interpret the number in an investment decision?
Start by separating four questions. How many XRP does the company report holding? What was the original cost basis? What did the reporting policy require at each measurement date? What is the value of that position at a specified market price and time? The filing answers the first three to varying levels of detail. The fourth must be calculated using a current, identified price source and the holdings at the same date; it changes as the market trades.
Next, assess the entire company. A corporate vehicle can have liabilities, preferred claims, fees, financing arrangements and future share issuance. Even a precise estimate of its XRP holdings' market value is not the same as its common-equity value. The 10-Q discloses refundable investor advances and business-combination terms that matter to that bridge. A simple “XRP value minus book value” calculation does not establish whether company shares are cheap or expensive.
Finally, avoid using the impairment as a directional XRP signal. It is historical accounting information for a particular reporting entity and period. It neither establishes that other holders are selling nor predicts the next XRP price. If a later filing changes the XRP unit balance, the policy conclusion, or the corporate structure, the analysis must be updated. This article explains the September 2026 filing as published; it is not a live valuation.
FAQ
Did Evernorth write down 60% in one quarter?
No. Approximately 60% is the cumulative gap between original additions and the September 2026 carrying value. The filing lists a separate $6.9 million impairment for the third quarter of 2026.
Is the $341.9 million balance the market value of its XRP?
No. It is the amount measured under the company's cost-less-impairment policy at 30 September 2026. A market estimate would require a specified XRP quantity, price, timestamp and any relevant liquidity or restriction assumptions.
Can a later XRP price recovery reverse the recorded impairment?
Under the policy Evernorth describes, the impaired basis is not written up for subsequent price increases. The company describes recognizing gains on disposition when proceeds exceed the carrying amount.
Does a digital-asset impairment prove a token sale?
No. An impairment is an accounting entry. Sales must be evaluated from the holdings and disposition disclosures, not inferred from the charge alone.






